Replimune (REPL) Selling, General & Administrative (2017 - 2026)
Replimune (REPL) reported Selling, General & Administrative of $18.97 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 41.8% from $32.58 million a year earlier and down 9.7% from the prior quarter.
Replimune (REPL) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Replimune's Selling, General & Administrative came in at $85.13 million, down 6.9% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $98.74 million, up 36.8% from FY2025.
- Selling, General & Administrative has increased for nine consecutive fiscal years, with a five-year compound annual growth rate of 33.6% (FY2021 to FY2026).
- By fiscal year, Selling, General & Administrative came in at $72.18 million in FY2025 (+20.7%), $59.81 million in FY2024 (+18.3%), $50.55 million in FY2023 (+30.4%) and $38.77 million in FY2022 (+67.1%).
- Five-year quarterly Selling, General & Administrative spans a low of $9.35 million in fiscal Q2 2022 and a high of $32.58 million in fiscal Q1 2026.
- Year over year, Selling, General & Administrative gained in six of the last eight quarters, with growth averaging 29.4%.
- The high point for year-over-year Selling, General & Administrative in five years was fiscal Q1 2026 (growth of 126.3%); the low point was fiscal Q1 2027 (a decline of 41.8%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $21.01 million (Q4 2026), $18.73 million (Q3 2026) and $26.41 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Replimune | 1.11 Bn | 1.11 Bn | - | 18.97 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.97 Mn |
| Mar 31, 2026 | 21.01 Mn |
| Dec 31, 2025 | 18.73 Mn |
| Sep 30, 2025 | 26.41 Mn |
| Jun 30, 2025 | 32.58 Mn |
| Mar 31, 2025 | 25.35 Mn |
| Dec 31, 2024 | 18.02 Mn |
| Sep 30, 2024 | 15.47 Mn |
| Jun 30, 2024 | 14.40 Mn |
| Mar 31, 2024 | 16.18 Mn |
| Dec 31, 2023 | 13.69 Mn |
| Sep 30, 2023 | 14.73 Mn |
| Jun 30, 2023 | 15.21 Mn |
| Mar 31, 2023 | 15.04 Mn |
| Dec 31, 2022 | 11.37 Mn |
| Sep 30, 2022 | 12.75 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 10.25 Mn |
| Dec 31, 2021 | 10.35 Mn |
| Sep 30, 2021 | 9.35 Mn |
Replimune Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();